Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes – PR Newswire (press release)
![]() Health Newstrack |
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
PR Newswire (press release) Immunogenicity-related events, including urticaria, were more common among Victoza-treated patients than among comparator-treated patients in clinical … FDA Approves Once-Daily LiraglutideMedPage Today all 448 news articles » |


